2017Infectious Diseases of Poverty6 (1) : 45
Seroprevalence of hepatitis B, hepatitis C, human immunodeficiency virus, Treponema pallidum, and co-infections among blood donors in Kyrgyzstan: a retrospective analysis (2013-2015)
Karabaev B, Beisheeva N, Satybaldieva A, Ismailova A, Pessler F, Akmatov M
2017Frontiers in Immunology8 : 246
Host Genetic Background Strongly Affects Pulmonary microRNA Expression before and during Influenza A Virus Infection
Preusse M, Schughart K, Pessler F
2017Human Vaccines & Immunotherapeutics13 (7) : 1630-1639
Establishment of a cohort for deep phenotyping of the immune response to influenza vaccination among elderly individuals recruited from the general population
Akmatov M, Riese P, May M, Jentsch L, Ahmed M, Werner D, Rösel A, Tyler M, Pessler K, Prokein J, Bernemann I, Klopp N, Prochnow B, Trittel S, Tallam A, Illig T, Schindler C, Guzmán C, Pessler F
2017Zeitschrift Fur Rheumatologie76 (6) : 539-546
Fifteen years of the histopathological synovitis score : Review and further developments of a diagnostic score
Krenn V, Perino G, Rüther W, Krenn V, Huber M, Hügle T, Najm A, Müller S, Boettner F, Pessler F, Waldstein W, Kriegsmann J, Häupl T, Wienert S, Krukemeyer M, Sesselmann S, Tikhilov R, Morawietz L
2017Scientific Reports7 (1) : 1855
Determination of nasal and oropharyngeal microbiomes in a multicenter population-based study - findings from Pretest 1 of the German National Cohort
Akmatov M, Koch N, Vital M, Ahrens W, Flesch-Janys D, Fricke J, Gatzemeier A, Greiser H, Günther K, Illig T, Kaaks R, Krone B, Kühn A, Linseisen J, Meisinger C, Michels K, Moebus S, Nieters A, Obi N, Schultze A, Six-Merker J, Pieper D, Pessler F
2018Antimicrobial Resistance and Infection Control7 : 21
Molecular characteristics and successful management of a respiratory syncytial virus outbreak among pediatric patients with hemato-oncological disease
Baier C, Haid S, Beilken A, Behnert A, Wetzke M, Brown R, Schmitt C, Ebadi E, Hansen G, Schulz T, Pietschmann T, Bange F
2018Virus Research248 : 53-62
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
Bartenschlager R, Baumert T, Bukh J, Houghton M, Lemon S, Lindenbach B, Lohmann V, Moradpour D, Pietschmann T, Rice C, Thimme R, Wakita T
2018Viruses10 (4) : 207
CD81 Receptor Regions outside the Large Extracellular Loop Determine Hepatitis C Virus Entry into Hepatoma Cells
Banse P, Moeller R, Bruening J, Lasswitz L, Kahl S, Khan A, Marcotrigiano J, Pietschmann T, Gerold G
2018Plos Pathogens14 (7) : e1007111
Hepatitis C virus enters liver cells using the CD81 receptor complex proteins calpain-5 and CBLB
Bruening J, Lasswitz L, Banse P, Kahl S, Marinach C, Vondran F, Kaderali L, Silvie O, Pietschmann T, Meissner F, Gerold G
2018Antimicrobial Agents and Chemotherapy62 (11) : e01206-18
The Small-Compound Inhibitor K22 Displays Broad Antiviral Activity against Different Members of the Family Flaviviridae and Offers Potential as a Panviral Inhibitor
García-Nicolás O, V'kovski P, Vielle N, Ebert N, Züst R, Portmann J, Stalder H, Gaschen V, Vieyres G, Stoffel M, Schweizer M, Summerfield A, Engler O, Pietschmann T, Todt D, Alves M, Thiel V, Pfaender S
